Surgical Oncology News

This section features a sampling of news related to surgical oncology from the popular press, from press releases received, or SSO news directly pertinent to SSO members.

  • Advances in the Management of Hepatic and Pancreatic Malignancies

    By: Perry Shen, MD, FACS, and Clancy Clark, MD, OncLiveApr 18, 2013
    The only opportunity for cure for hepatic and pancreatic malignancies is surgical resection. Therefore, Wake Forest Baptist Health Comprehensive Cancer Center has introduced a multidisciplinary, multifaceted approach to the surgical management of hepatic and pancreatic malignancies. As a high-volume center for hepatobiliary and pancreatic procedures, Wake Forest Baptist Health provides ...
  • Australian Doctors to be hit with higher CPD costs

    By: Paul Smith, Oncology updateApr 17, 2013
    The government said tax deductions were currently unlimited, allowing people to "enjoy significant private benefits at taxpayers' expense", including first-class airfares and five-star hotels. But the decision has been blasted by AMA president Dr Steve Hambleton, who warned that the new cap fell well below "many basic medical course costs". Read ...
  • Ipilimumab plus surgery boosted advanced melanoma survival

    By: Neil Osterweil, Oncology Report Digital NetworkApr 10, 2013
    Patients with stage IV melanoma treated with a combination of ipilimumab and surgical resection had a high rate of melanoma-specific and overall survival, a retrospective study of a single-center case series has shown. "To our knowledge, this is the first report of 5-year melanoma-specific survival data on patients who have ...
  • Important News from ABS about MOC Part 2

    By: The American Board of SurgeryMar 27, 2013
    In recent months, the ABS has announced several changes to Part 2 of Maintenance of Certification (MOC): As of January 2012, Category II CME is no longer required for MOC or recertification. Diplomates in MOC must complete 90 hours of Category I CME over a three-year cycle. As of July ...
  • Surgery may be avoided in early rectal cancer

    By: Neil Osterweil, Oncology Report Digital NetworkMar 26, 2013
    Approximately 10%-25% of patients with locally advanced rectal cancer will have clinical complete responses (cCR) to neoadjuvant chemotherapy and radiation, said Dr. Philip B. Paty, an attending surgeon in the colorectal surgery service at Memorial Sloan-Kettering Cancer Center in New York City. "The vast majority of these patients will avoid ...